Phase 2 study assesses safety and efficacy of topical pravibismane in subjects suffering from moderate infections associated with chronic diabetic foot ulcers BOZEMAN, Mont. and VANCOUVER, BC, March 9, 2023 /PRNewswire/ – Microbion Corporation today announced that a Phase 2, randomized,…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.